HPV Prevention and Control Board created a survey about how COVID-19 has affected the cervical screening The COVID-19 pandemic has brought about multiple complex challenges in 2020 including the provision of laboratory services required to support cervical cancer screening programmes. The HPV Prevention and Control Board decided to create a short survey, led by Mario Poljak and Kate Cuschieri, to collect contemporary data on the experience of laboratories on how COVID-19 has affected the ability to deliver “routine” services required to support cervical cancer screening. The Aims of the Survey: The survey is intended for heads of laboratories and/or laboratory managers; in this way, we would hope to capture a single response per laboratory. The survey will help to both quantify the impact and identify common challenges across laboratories, both existing and anticipated. HPV Prevention and Control Board Survey: challenges of laboratory services required to support cervical cancer screening programmes This article was published on 2022-07-12
